Evaluation of the effects of anakinra treatment on clinic and laboratory results in patients with COVID-19

OBJECTIVE: Some anti-cytokine treatments are being used to control the hyperinflammatory condition defined as cytokine storm that develops during COVID-19 infection. In this study, we aim to investigate the effects of anakinra, an IL-1 antagonist, on the clinical status and laboratory values of hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Siyer, Ozge, Aksakal, Berrin, Basat, Sema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2023
Materias:
Orıgınal Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170373/
https://www.ncbi.nlm.nih.gov/pubmed/37181065
http://dx.doi.org/10.14744/nci.2022.01047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170373/
https://www.ncbi.nlm.nih.gov/pubmed/37181065
http://dx.doi.org/10.14744/nci.2022.01047

Ejemplares similares